1
0
0
News
Delphi Diagnostics SET2,3 Test Clarifies Therapy Options for …
www.precisiononcologynews.com
· SET2,3 and SET ER/PR were developed at MD Anderson Cancer Center by Fraser Symmans, a professor of pathology. Both have been licensed to Houston, Texas-based Delphi Diagnostics, where they are in advanced stages of development in preparation for …
W. Fraser Symmans – The Katy Newsthekatynews.com › tag › w-fraser-symmans
thekatynews.com
The study's results were presented by W. Fraser Symmans, M.D., professor of Pathology, during the San Antonio Breast Cancer ...
Genomic Test Shows Promise as Predictor of Chemotherapy...
www.mdanderson.org
... breast cancer who are candidates for chemotherapy,” says W. Fraser Symmans, M.D., professor in MD Anderson's Department of Pathology.
Genetic Test Shows Promise in Guiding Breast Cancer Careconsumer.healthday.com › cancer-information-5 › gen...
consumer.healthday.com
According to the study's lead author, Dr. W. Fraser Symmans, gene-based tests such as the Oncotype DX are already in wide used to help ...
Telephone & Addresses
Fraser W Symmans, New York, Washington Square Vlg
View W. Fraser's social profiles and photos on Facebook, MySpace, and +40 Networks.
WhitePages: William F Symmans MD in | Whitepages
View phone details, business hours, full address for William F Symmans MD in Whitepages is the most trusted online directory.
Network Profiles
The I-SPY Clinical Trials
www.ispytrials.org
The I-SPY Clinical Trials. Dr. Fraser Symmans is Professor and Director of Research Operations in the Department of Pathology at MD Anderson Cancer Center, where he practices Breast Surgical Pathology and Cytopathology and also directs the Breast Cancer Pharmacogenomics Laboratory. He received his medical degree from the University of Auckland ...
W. Fraser Symmans | Semantic Scholarwww.semanticscholar.org › author › W.-Fraser-Symmans
www.semanticscholar.org
Semantic Scholar profile for W. Fraser Symmans, with 20 highly influential citations and 7 scientific research papers.
Interests
New MD Anderson-developed breast cancer staging system emphasizes...
www.eurekalert.org
A new breast cancer staging system developed by researchers at The University of Texas
MD Anderson Cancer Center finds that incorporating tumor biology is a...
Two groundbreaking studies reflect new paradigm in breast cancer...
www.sciencedaily.com
In a new paradigm of breast cancer research, physicians are fast-tracking promising new experimental drugs for further study, while immediately dropping drugs...
Residual cancer burden after neoadjuvant therapy can ...www.eurekalert.org › pub_releases › uotm-rcb
www.eurekalert.org
Fraser Symmans, M.D., professor of Pathology, during the San Antonio Breast Cancer Symposium. "This meta-analysis indicates that ...
Will Breast Cancer Recur? New Microarray Tests Help With ...www.sciencedaily.com › releases ›
www.sciencedaily.com
... and patients considering treatment options, says W. Fraser Symmans, M.D., professor in M. D. Anderson's Department of Pathology. "Existing ...
Books & Literature
W. Fraser Symmans, MD | Cancer Networkwww.cancernetwork.com/authors/w-fraser-symmans-md
www.cancernetwork.com
W. Fraser Symmans, MD. Apr 18, In their review of multi-gene assays of breast cancer, Drs. Gökmen-Polar and Badve highlight the overall similarity of ...
Auflistung nach Autor "Fraser Symmans, W"
www.duo.uio.no
... Lluch, Ana; Aparicio, Sam; Brown, Powel; Pusztai, Lajos; Fraser Symmans, W; Alsner, Jan; Overgaard, Jens; Borresen-Dale, Anne-Lise; Hortobagyi, Gabriel N; ...
Auflistung BioMed Central høstingsarkiv nach Autor "Fraser Symmans,...
www.duo.uio.no
Browsing BioMed Central høstingsarkiv by Author "Fraser Symmans, W" ... Brown, Powel; Pusztai, Lajos; Fraser Symmans, W; Alsner, Jan; Overgaard, Jens; ...
Advanced Therapy of Breast Disease - Page Google Books Resultbooks.google.se › books
books.google.se
CHAPTER 17 BREAST CANCER S. EVA SINGLETARY, MD W. FRASER SYMMANS, MD For over 100 years, oncologists have recognized that the morphologic ...
Related Documents
Fraser Symmans - Academia.edu
independent.academia.edu
Fraser Symmans studies Stratification, Mutation, and Breast Cancer.
W Fraser Symmans - Home
dl.acm.org
Search within W Fraser Symmans's work. Search Search. Home W Fraser Symmans. W Fraser Symmans. Skip slideshow. Most frequent co-Author ...
Residual Cancer Burden Can Predict Outcomes for Patients With …
www.sabcs.org
the study’s lead author, W. Fraser Symmans, MD, professor and director of research operations, Department of Pathology, at The University of Texas MD Anderson Cancer Center in Houston. “We undertook this meta-analysis to help determine whether this is true for all subtypes, and how generalizable previous findings might be.”
AD AWARD NUMBER: DAMD PRINCIPAL …
www.dtic.mil
W. Fraser Symmans, M.D Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. 2 Department of Pathology, University of …
Scientific Publications
A Pathologist’s Perspective on Emerging Genomic Tests for Breast...
www.sciencedirect.com
A Pathologist’s Perspective on Emerging Genomic Tests for Breast Cancer. W. Fraser Symmans. x. W. Fraser Symmans. Search for articles by this author …
Amplification of fibroblast growth factor receptor-1 in breast cancer...
pubmed.ncbi.nlm.nih.gov
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to...
Genomic Grade Index Is Associated With Response to Chemotherapy in...
www.ncbi.nlm.nih.gov
The genomic grade index (GGI) is a 97-gene measure of histological tumor grade William Fraser Symmans, Christine Desmedt, Benjamin Haibe-Kains, ...
Breast Cancer Research | Editorial board
breast-cancer-research.biomedcentral.com
Breast Cancer Research is the highest ranking breast cancer-specific title in the top quartile of oncology journals worldwide. Primarily publishing original ...
Publications
W Fraser Symmans's Research on Neoplasms (Cancer) | CureHunter
www.curehunter.com
W Fraser Symmans Selected Research. Neoplasms (Cancer) : Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group :
SciFeed - MDPIwww.mdpi.com › scifeed_display
www.mdpi.com
Paolo Nuciforo. Anne Vincent-Salomon. Fraser Symmans. Giovanni Apolone. Filippo G. de Braud. Marilena V. Iorio. Paolo Verderio. Maria Grazia Daidone ...
Histopathologic and Molecular Markers of Prognosis and ...link.springer.com › chapter
link.springer.com
Histopathologic and Molecular Markers of Prognosis and Response to Therapy. Authors; Authors and affiliations. Lajos Pusztai; W. Fraser Symmans.
Video & Audio
William Fraser Symmans on Vimeo
vimeo.com
This is "William Fraser Symmans" by M3 USA on Vimeo, the home for high quality videos and the people who love them.
Reports & Statements
ASCO Early-Stage Breast Cancer Updates | BCRF
www.bcrf.org
The SET2,3 test developed with BCRF support by Dr. W. Fraser Symmans is a gene-based assay that measures the level of estrogen-induced gene activation in breast cancer cells. Presenting results from the phase 3 CALGB study, ...
SET ER/PR : a robust 18-gene predictor for sensitivity to ...www.nature.com › npj breast cancer › articles
www.nature.com
... V. Vicente Valero &; W. Fraser Symmans. npj Breast Cancer volume 5, Article number: 16 (2019) Cite this article Accesses. 1 Citations.
Latest biopsy approach for suspected metastases in patients with...
www.nature.com
Biopsy of suspected metastatic lesions is recommended, but not always performed in the clinic. Niikura and colleagues outline the rationale and techniques for...
Miscellaneous
William Fraser Symmans - Google Scholar
scholar.google.com
William Fraser Symmans. Professor of Pathology, University of Texas MD Anderson Cancer Center. Verified email at mdanderson.org. breast cancer. Articles Cited by Public access Co-authors. Title. Sort. Sort by citations Sort by year Sort by title. Cited by. Cited by. Year;
W. Fraser Symmans M.D's research works | University of Texas …
www.researchgate.net
W. Fraser Symmans M.D's 6 research works with 373 citations and 144 reads, including: Differential Gene and Protein Expression in Primary Breast Malignancies and Their Lymph Node Metastases as ...
W. Fraser Symmans: H-index & Awards - Academic Profile
research.com
W. Fraser Symmans has researched Cancer in several fields, including Phenotype and Endocrinology. The various areas that W. Fraser Symmans examines in his Chemotherapy study include Anthracycline and Predictive marker. His Neoadjuvant therapy research integrates issues from Regimen and Clinical endpoint.
W. Fraser Symmans | Researcher | BCRF
www.bcrf.org
Dr. Fraser Symmans is Professor and Director of Research Operations in the Department of Pathology at MD Anderson Cancer Center, where he practices Breast Surgical Pathology and Cytopathology and also directs the Breast Cancer Pharmacogenomics Laboratory. He received his medical degree from the University of Auckland, New Zealand, completed his ...
Fraser Symmans | LinkedIn
www.linkedin.com
View Fraser Symmans's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Fraser Symmans discover inside ...
Fraser Symmans - MD Anderson Cancer Center, Houston
allpeople.com
Fraser Symmans. Associate Professor at MD Anderson Cancer Center · Houston. Search Background Check Edit Listing. MD Anderson Cancer Center Business Data Holcombe Blvd, Houston, TX , Texas (713) mdanderson.org.
Fraser Symmans - The University of Texas., Houston
allpeople.com
Found colleagues at The University of Texas.. There are 2 other people named Fraser Symmans on AllPeople. Contact info: Find more info on AllPeople about Fraser Symmans and The University of Texas., as well as people who work for similar businesses nearby, colleagues for other branches, and more people with a similar name.
W Fraser Symmans's research works | University of Texas MD …
www.researchgate.net
W Fraser Symmans's 614 research works with 31,391 citations and 6,636 reads, including: Abstract 1595: Analysis of spatiotemporal phenotypic heterogeneity in chemoresistant triple negative breast ...
Fraser Symmans - Professor - The University of Texas MD ...www.linkedin.com › fraser-symmans
www.linkedin.com
View Fraser Symmans' profile on LinkedIn, the world's largest professional community. Fraser has 1 job listed on their profile. See the complete profile on ...
Fraser Symmans | Professional Profile - LinkedIn
www.linkedin.com
View Fraser Symmans' professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Fraser Symmans discover ...
Author Page for W. Fraser Symmans :: SSRN
papers.ssrn.com
Total downloads of all papers by W. Fraser Symmans. Skip to main content. Feedback to SSRN. Feedback (required) Email (required) Submit If you need immediate assistance, call 877-SSRNHelp ( ) in the United States, or + outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.
Pathology Outlines - William Fraser Symmans, M.B.Ch.B.
www.pathologyoutlines.com
· William Fraser Symmans, M.B.Ch.B. Institution: University of Texas MD Anderson Cancer Center. Location: USA. Subspecialties: Blood bank / transfusion medicine, Breast, Cytopathology. Research Interests. Developing gene based prognostics tests to guide treatment decisions for patients with estrogen receptor positive breast cancer.
Breast Neoplasms: Symmans, F - Expertscape.com
expertscape.com
Articles by Fraser Symmans: Based on 7 eligible articles published since What is "eligible"? More database statistics are available. |||| Between and 2021, F. Symmans wrote the following 7 eligible articles about Breast Neoplasms: + Citations-Citations + Abstracts-Abstracts. 1: Review: Update on tumor ...
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy …
ascopubs.org
JOURNAL OF CLINICAL ONCOLOGY ORIGINAL REPORT Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype W. Fraser Symmans, Caimiao Wei, Rebekah Gould, …
Residual Cancer Burden Predicts Patient Outcomes Across
www.onclive.com
· W. Fraser Symmans, MD. Residual cancer burden (RCB) after neoadjuvant chemotherapy has been shown to be an accurate long-term predictor of disease recurrence and survival across all breast cancer ...
WO A3 - Method of measuring residual cancer and predicting...
patents.google.com
Disclosed is a method for determining survival and relapse of a patient undergoing therapy for a tumor by determining a residual cancer burden index...
WO A3 - Bifunctional predictors of cancer treatment...
patents.google.com
Inventors, Christos Hatzis, Lajos Pusztai, Fraser W Symmans. Applicant, Christos Hatzis, Nuvera Biosciences Inc, Lajos Pusztai, Fraser W Symmans, Univ Texas.
William Fraser Symmans, MD Professor, Pathology University of Texas...
docplayer.net
1 Perspectives with Prognostic and Predictive Factors William Fraser Symmans, MD Professor, Pathology University of Texas MD Anderson Cancer Center Dr.
Hortobágyi Jeffrey S. Ross, Christos Hatzis, W. Fraser Symmans ...
www.semanticscholar.org
JEFFREY S. ROSS,a CHRISTOS HATZIS,b W. FRASER SYMMANS,c LAJOS PUSZTAI,d. GABRIEL N. HORTOBÁGYI d. aDepartment of Pathology and ...
Related search requests for W. Fraser Symmans
| Lajos Pusztai Peter Schraml Andreas Turzynski |
People Forename "Fraser" (1361) Name "Symmans" (3) |
sorted by relevance / date